India's healthcare sector is in ICU, time for the FM to write it a big fat cheque

Globally, COVID-19 has disrupted lives in an unprecedented fashion and no country has managed to escape ill effects of the pandemic with India being no exception. The current crises have raised questions and exposed shortcomings in the healthcare delivery services in some of the most advanced economies of the world. Yet, as the scientific community across countries strive to find a cure for this virus, there may be a silver lining to this pandemic…focus on health and healthcare in general.

In 2020, it was imperative for organizations to find innovative solutions to sustain themselves, virtually becoming “Technology companies” by adopting IT as a major enabler in their functioning. Similarly, in 2021, organizations must focus on the well-being of their customers, both internal (employees) as well as external and become “Healthcare companies” to sustain businesses.

As the pandemic unfolded and the outbreak spread all parts of the country, the healthcare sector had to unlearn, learn, innovate and adapt to the evolving disease dynamics. Virtual care and remote medicine became the need of the hour with Tele-consultations and remote monitoring being adopted across geographies to manage chronic ailments. Hospital footfalls dropped drastically with residential emergency centers and home-based care becoming the norm, especially among the vulnerable and elderly members of the community.

Across India, most communities witness high population densities with the ratios getting exaggerated in urban areas. Our government agencies were quick to assess the scale and enormity of the challenge posed by the pandemic.

India, which was not manufacturing even a single personal protective equipment (PPE) kit, became one of the manufacturing hubs and achieved self-sufficiency, producing in excess of 4 lakh PPE kits daily within a few months after the coronavirus outbreak. Similar efforts were put in place towards building uninterrupted supply chains for pharmaceuticals, ventilators, laboratory tests, N-95/ surgical masks, hand sanitizers and essential medical gases.


Source: Economictimes